延髓麻痹患者并发肺部感染的临床调查  

Bulboparalysis Patients Complicated with Pulmonary Infection:A Clinical Investigation

作　　者：金笑平[1] 江毅卿[1] 王莹[1] 蒋辉华[1] 柯绍发[1] 陈秋月[1] 周元林[1] 王恩[1] 黄勤[1] 张丹红[1] 

机构地区：[1]浙江省台州医院神经内科,浙江临海317000

出　　处：《中华医院感染学杂志》2009年第3期283-285,共3页Chinese Journal of Nosocomiology

摘　　要：目的了解延髓麻痹患者并发肺部感染的病原菌流行及耐药情况。方法采用回顾性调查的方法,对延髓麻痹患者212例,分析其肺部感染病原菌分布特点及耐药率。结果212例延髓麻痹患者并发肺部感染发生率为30.2%(64例),比同期同病房患者并发肺部感染发生率(2.1%)高;延髓麻痹并发肺部感染的感染菌以革兰阳性菌为主,占68.8%,革兰阳性菌中又以金黄色葡萄球菌为主。结论延髓麻痹并发肺部感染且病情危重者,如影像学资料及痰涂片结果支持金黄色葡萄球菌感染,可考虑万古霉素治疗。OBJECTIVE To study the epidemic and drug resistance of the bacteria in the bulboparalysis patients complicated with pulmonary infection. METHODS The bacteriology distribution and drug resistance in the 212 cases of bulboparalysis patients complicated with pulmonary infection, were analyzed retrospectively. RESULTS From the 212 cases, the occurrance of pulmonary infection was 30.2V0 （64 cases）, 2.1% higher than that in the same ward. The major pathogens were Gram-positives （68. 0%）, and the top was Staphylococcus. CONCLUSIONS Vancomycin treatment can be chosen if the image data and phlegm smear results supporting Staphylococcus infection in bulboparalysis patients complicated with pulmonary infection and seriously ill.

关 键 词：延髓麻痹 肺部感染 病原菌 

分 类 号：R181.32[医药卫生—流行病学]